Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)
Curr Pharmacogenomics Person Med, 2011 December, 9(4): 243-251
The Millennium Summit in 2000 established the Millennium Development Goals (MDGs), which were agreed upon by 193 countries and 23 international organizations to combat extreme poverty and other pressing global priorities for human development. In the December 2011 issue of CPPM, Borda-Rodriguez and Huzair present an analysis of the close ties and synergies among the MDGs, pharmacogenomics and personalized medicine. Notably, MDGs promote the creation of collective innovation, a concept with both substantive and instrumental pertinence for the personalized medicine R&D that is currently undergoing rapid globalization. The ethos for collective innovation in global health is also embodied in the Paris Declaration on Aid Effectiveness, endorsed in 2005 by more than 100 signatories, including donor and developing country governments, regional development banks and international aid agencies.
Ozdemir, Vural and Rosenblatt, David and Warnich, Louise and Srivastava, Sanjeeva and Tadmouri, Ghazi and Aziz, Ramy and Reddy, Panga and Manamperi, Aresha and Dove, Edward and Joly, Yann and Zawati, Ma'n H. and Hızel, Candan and Yazan, Yasemin and John, Leela and Vaaste, Emmanuelle and Ptolemy, Adam and Faraj, Samer and Kolker, Eugene and Cotton, Richard, Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA) (December 1, 2011). Curr Pharmacogenomics Person Med, 2011 December, 9(4): 243-251, Available at SSRN: https://ssrn.com/abstract=2201774
Download This Paper